Anaptysbio (ANAB) Return on Capital Employed Growth (3y) (2020 - 2026)
Anaptysbio (ANAB) Return on Capital Employed Growth (3y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,561.01 Bn | 66,560.72 Bn | - | - |
| 2 | Nanobiotix | 1,912.79 Bn | 1,912.72 Bn | - | - |
| 3 | Akari Therapeutics | 1,045.06 Bn | 1,045.06 Bn | - | - |
| 4 | BeOne Medicines | 469.79 Bn | 465.00 Bn | 1.35 Bn | 4,893.00 |
| 5 | Vertex Pharmaceuticals | 122.95 Bn | 115.70 Bn | 2.59 Bn | -494.00 |
| 6 | Regeneron Pharmaceuticals | 70.05 Bn | 61.30 Bn | 3.31 Bn | -649.00 |
| 7 | Belite Bio | 62.62 Bn | 62.62 Bn | - | - |
| 8 | Argenx Se | 56.18 Bn | 50.99 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | -3,782.00 |
| 10 | Anaptysbio | 1.56 Bn | 1.27 Bn | - | 3,680.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3,680.00 |
| Dec 31, 2025 | 3,453.00 |
| Sep 30, 2025 | 1,102.00 |
| Jun 30, 2025 | -871.00 |
| Mar 31, 2025 | -1,310.00 |
| Dec 31, 2024 | -1,496.00 |
| Sep 30, 2024 | -3,729.00 |
| Jun 30, 2024 | -4,064.00 |
| Mar 31, 2024 | -3,272.00 |
| Dec 31, 2023 | -3,175.00 |
| Sep 30, 2023 | -1,046.00 |
| Jun 30, 2023 | -581.00 |
| Mar 31, 2023 | -58.00 |
| Dec 31, 2022 | 639.00 |
| Sep 30, 2022 | 365.00 |
| Jun 30, 2022 | 288.00 |
| Mar 31, 2022 | 446.00 |
| Dec 31, 2021 | 252.00 |
| Sep 30, 2021 | 1,567.00 |
| Jun 30, 2021 | 1,328.00 |